Safety During Clinical Trials is my Priority
Clients
Send this page to a friend
Our Services
Phase I/IIa
We have an outstanding 35 years safe and compliant track record in Phase I/IIa drug development clinical trials.
Bioequivalence
We provide a wide range of services for bioequivalence and bioavailability studies to the generic industry.
505(b)(2)-Generic Hybrid
Through key alliances, our team of experts can help you design and conduct your 505(b)(2) study successfully.
Bioanalysis
Our bioanalytical facilities share more than 500 validated methods for drugs, metabolites and biomarkers.
Central Lab
Our GLP/GCP compliant Central Laboratory Services provide essential supporting analyses for Phase I-IV trials.
-
Join us!
-
News
-
March 28-29, 2012
6th Workshop on Recent Issues in Bioanalysis
San Antonio, Texas, US -
May 21-23, 2012
2012 National Biotechnology Conference
San Diego, California, US




